Temporal analysis of the rat's behavior in the plus-maze: Effect of midazolam

Pharmacology Biochemistry and Behavior

Volumn 67, Issue 1, 2000, Pages 177-182

  Rosa, V P ^a   Vandresen, N ^a   Calixto, A V ^a   Kovaleski, D F ^a   Faria, M S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Anxiolysis; Elevated plus maze; Exploration; Fear; Midazolam; Rat

Indexed keywords

MIDAZOLAM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; EXPLORATORY BEHAVIOR; HABITUATION; MALE; MAZE TEST; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RAT; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MIDAZOLAM; RATS; RATS, WISTAR;

EID: 0033667014     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00316-6     Document Type: Article

References (22)

1. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety
2. Ethopharmacological analysis of rat behavior on the elevated plus-maze
3. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure
4. Use of the elevated plus-maze in the search for novel anxiolytic agents
5. Effects of weekly or daily exposure to the elevated plus-maze in male mice
6. The influence of open arms ledges and maze experience in the elevated plus-maze
7. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze
8. Behavioural detection of anxiolytic action
9. The interplay of learning and anxiety in the elevated plus-maze
10. 'One-trial tolerance' to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
11. Trial 2 in the elevated plus-maze: A different form of fear?
12. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs
13. Effects of α2-adrenoceptor agonists and antagonists a maze exploration model of fear-motivated behaviour
14. Review of the validity and variability of the elevated plus-maze as an animal model of anxiety
15. Responses of swiss-webster mice to repeated plus-maze experience: Further evidence for a qualitative shift in emotional state?
16. The use of a plus-maze to measure anxiety in the mouse
17. The relation between fear induced by novelty stimulation and exploratory behaviour
18. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
19. The elevated plus-maze: Pharmacology, methodology and ethology
20. Plus-maze retest profile in mice: Importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockade
21. Preliminary evaluation of an elevated 'zero-maze' as a model of anxiety in laboratory rats
22. Anxiogenic stimuli in the elevated plus-maze